Showing results (101-110 of 586) with videos related to
Sort By:
Pageof 59
Antimicrobial Agents and Chemotherapy|January 1, 1991
In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinationsP C Fuchs, S Stickel, P H Anderson, et al.Antimicrobial Agents and Chemotherapy|July 1, 1983
In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limitsP C Fuchs, A L Barry, C Thornsberry, et al.Journal of Clinical Microbiology|April 1, 1992
Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeaeP C Fuchs, A L Barry, C Baker, et al.The Journal of Antibiotics|March 1, 1978
Stability of antimicrobials in Schaedler's anaerobic and brain heart infusion broths stored at --20 degrees CR N Jones, R R Packer, P C Fuchs, et al.Antimicrobial Agents and Chemotherapy|August 1, 1981
Mezlocillin: tentative interpretive standards for disk diffusion susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.Journal of Clinical Microbiology|October 1, 1991
Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacinP C Fuchs, A L Barry, C Baker, et al.American Journal of Clinical Pathology|November 1, 1986
The anti-microbial activity, beta-lactamase stability, and disk diffusion susceptibility testing of carumonam (RO 17-2301, AMA-1080), a new monobactamR N Jones, A L Barry, C Thornsberry, et al.Journal of Clinical Microbiology|August 1, 1992
Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinationsP C Fuchs, A L Barry, C N Baker, et al.Antimicrobial Agents and Chemotherapy|April 1, 1991
Multicenter evaluation of the in vitro activities of three new quinolones, sparfloxacin, CI-960, and PD 131,628, compared with the activity of ciprofloxacin against 5,252 clinical bacterial isolatesP C Fuchs, A L Barry, M A Pfaller, et al.The Journal of Antimicrobial Chemotherapy|June 1, 1993
Methods for testing the susceptibility of anaerobic bacteria to two fluoroquinolone compounds, PD 131628 and clinafloxacinA L Barry, P C Fuchs, D M Citron, et al.Pageof 59